Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
المصدر:
Nasdaq GlobeNewswire
/
15 سبتمبر 2025 05:35:40 America/Los_Angeles
N/A
شارك على،